§ 27-55-1 Definitions. – For the purpose of this chapter, the following words and terms have thefollowing meanings:
(1) "FDA" means the Federal Food and Drug Administration;
(2) "Health insurer" means all persons, firms, corporationsor other organizations offering and assuring health services on a prepaid orprimarily expense incurred basis including, but not limited to, policies ofaccident or sickness insurance, as defined in chapter 18 of this title,nonprofit hospital or medical service plans, whether organized under chapter 19or 20 of this title or under any public law or by special act of the generalassembly, health maintenance organizations, and any other entity, which insuresor reimburses for diagnostic, therapeutic or preventive services to adetermined population on the basis of a periodic premium;
(3) "Medical literature" means published scientific studiespublished in at least two (2) articles from major peer reviewed medicaljournals that present data supporting the proposed off-label use or uses asgenerally safe and effective unless there is clear and convincing contradictoryevidence presented in a major peer reviewed medical journal;
(4) "Standard reference compendia" means: (i) the UnitedStates Pharmacopoeia drug information, (ii) the American Medical Associationdrug evaluations, or (iii) the American Hospital Formulary Service druginformation;
(5) "Drug" means the primary anti-cancer or antineoplasticagent or agents.
§ 27-55-1 Definitions. – For the purpose of this chapter, the following words and terms have thefollowing meanings:
(1) "FDA" means the Federal Food and Drug Administration;
(2) "Health insurer" means all persons, firms, corporationsor other organizations offering and assuring health services on a prepaid orprimarily expense incurred basis including, but not limited to, policies ofaccident or sickness insurance, as defined in chapter 18 of this title,nonprofit hospital or medical service plans, whether organized under chapter 19or 20 of this title or under any public law or by special act of the generalassembly, health maintenance organizations, and any other entity, which insuresor reimburses for diagnostic, therapeutic or preventive services to adetermined population on the basis of a periodic premium;
(3) "Medical literature" means published scientific studiespublished in at least two (2) articles from major peer reviewed medicaljournals that present data supporting the proposed off-label use or uses asgenerally safe and effective unless there is clear and convincing contradictoryevidence presented in a major peer reviewed medical journal;
(4) "Standard reference compendia" means: (i) the UnitedStates Pharmacopoeia drug information, (ii) the American Medical Associationdrug evaluations, or (iii) the American Hospital Formulary Service druginformation;
(5) "Drug" means the primary anti-cancer or antineoplasticagent or agents.
§ 27-55-1 Definitions. – For the purpose of this chapter, the following words and terms have thefollowing meanings:
(1) "FDA" means the Federal Food and Drug Administration;
(2) "Health insurer" means all persons, firms, corporationsor other organizations offering and assuring health services on a prepaid orprimarily expense incurred basis including, but not limited to, policies ofaccident or sickness insurance, as defined in chapter 18 of this title,nonprofit hospital or medical service plans, whether organized under chapter 19or 20 of this title or under any public law or by special act of the generalassembly, health maintenance organizations, and any other entity, which insuresor reimburses for diagnostic, therapeutic or preventive services to adetermined population on the basis of a periodic premium;
(3) "Medical literature" means published scientific studiespublished in at least two (2) articles from major peer reviewed medicaljournals that present data supporting the proposed off-label use or uses asgenerally safe and effective unless there is clear and convincing contradictoryevidence presented in a major peer reviewed medical journal;
(4) "Standard reference compendia" means: (i) the UnitedStates Pharmacopoeia drug information, (ii) the American Medical Associationdrug evaluations, or (iii) the American Hospital Formulary Service druginformation;
(5) "Drug" means the primary anti-cancer or antineoplasticagent or agents.
